logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Philip Joos

tilburg university

14H指数
48论文数
1.2K被引数
收录论文 4
发表时间
logo
Research and Development Costs of New Drugs
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2020-08-04
err1
PREAI
errDierynck, Bart; Joos, Philip
err分享
err收藏
Determinants and Valuation Implications of Compulsory Stock Option Disclosures in a Weak Regulatory SettingThe Case of France
errJOURNAL OF INTERNATIONAL FINANCIAL MANAGEMENT & ACCOUNTING
IF8.2
err2015-10-06
err8
PREAI
errGoh, Lisa; Joos, Philip; Soonawalla, Kazbi
err分享
err收藏
Investor Perceptions of Potential IFRS Adoption in the United States
errACCOUNTING REVIEW
IF4.4
err2012-10-01
err57
PREAI
errJoos, Philip P. M.; Leung, Edith
err分享
err收藏
IPO failure risk
errJOURNAL OF ACCOUNTING RESEARCH
IF6.3
err2007-03-16
err97
PREAI
errDemers, Elizabeth; Joos, Philip
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
E
Elizabeth Demers
H 指数: 20 · 论文数: 58
B
Bart Dierynck
H 指数: 10 · 论文数: 73
K
Kazbi Soonawalla
H 指数: 10 · 论文数: 21
E
Edith Leung
H 指数: 7 · 论文数: 13
L
Lisa Goh
H 指数: 6 · 论文数: 18
已加载全部